CPS1 and non-small cell lung carcinoma: The genotype further conditions the benefit: in LKB1-mutant NSCLC, dexamethasone upregulates CDKN1C/p57 and enforces G1/S arrest, nominating LKB1/CPS1 as selection markers for GR-directed strategies [39].